T cells are supposed to be relentless. These white blood cells patrol the body, identify threats, and destroy them.

Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a set of novel, ...

The controlled, randomised global Phase III trial will enrol 830 patients.

St. Jude Children's Research Hospital scientists have discovered how tumors disable immune "gatekeeper" cells that alert the ...

Researchers have uncovered a previously hidden “internal brake” on immune cells that limits their ability to fight cancer, ...

FAK blocker + chemo + immunotherapy drew immune cells into ovarian tumors in mice. Promising preclinical data; trials next.

Scientists at UC San Diego and Sanford Burnham Prebys say combining drugs that inhibit a problem protein with immunotherapy ...

Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has reached a significant ...

The FDA has granted Fast Track Designation to CTIM-76, a claudin-6 (CLDN6) x CD3 T cell engaging bispecific antibody, for the ...

Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung ...

A new approach engineers immune cells to recognize byproducts of cancer cells to trigger migration toward the tumor.

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), th cancer immunotherapy developer, has named David Schilansky as ...